Experienced in Rheumatic Fever

Dr. Keith Allen

Cardiology
Office
4320 Wornall Rd Ste 50, 
Kansas City,, MO 
Clinical Trials:Currently Recruiting for 3 Trials
Experienced in Rheumatic Fever
Office
4320 Wornall Rd Ste 50, 
Kansas City,, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Keith Allen is a Cardiologist in Kansas City,, Missouri. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Rheumatic Fever. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 87 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Thoracic Surgery (Cardiothoracic Vascular Surgery) in MO
Hospital Affiliations
Hedrick Medical Center
Saint Luke's East Hospital
St Lukes Hospital Of Kansas City
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Office
4320 Wornall Rd Ste 50, Kansas City,, MO 64111
Other Locations
Saint Luke's Hospital Valve & Vascular Clinic
4320 Wornall Rd Ste 620, Kansas City,, MO 64111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Device
Study Phase: Not Applicable
Safe & Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D): Prospective, Multicenter, Double-blind, Randomized Study of Apixaban & Rivaroxaban Removal to Reduce Risk of Serious Bleeding in Urgent Cardiac Surgery Patients
Safe & Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D): Prospective, Multicenter, Double-blind, Randomized Study of Apixaban & Rivaroxaban Removal to Reduce Risk of Serious Bleeding in Urgent Cardiac Surgery Patients
Enrollment Status: Terminated
Publish Date: May 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
Safe, Timely Antithrombotic Removal-Ticagrelor (STAR-T): Double-blind Randomized Study of Reduction in Bleeding by Ticagrelor Removal Via Intraop Use of DrugSorb-Antithrombotic Removal (ATR) in Cardiac Surgery Patients <2 Days of Drug Stop
Safe, Timely Antithrombotic Removal-Ticagrelor (STAR-T): Double-blind Randomized Study of Reduction in Bleeding by Ticagrelor Removal Via Intraop Use of DrugSorb-Antithrombotic Removal (ATR) in Cardiac Surgery Patients <2 Days of Drug Stop
Enrollment Status: Completed
Publish Date: April 11, 2025
Intervention Type: Device
Study Phase: Not Applicable
Sternal Rigid Fixation: Evaluation of Clinical Outcomes Using Real-World Evidence
Sternal Rigid Fixation: Evaluation of Clinical Outcomes Using Real-World Evidence
Enrollment Status: Terminated
Publish Date: July 23, 2021
Intervention Type: Device
View 5 Less Clinical Trials

87 Total Publications

Transcatheter Mitral Valve Replacement for Severe Mitral Annular Calcification: Primary Outcomes from the SUMMIT-MAC Study.
Transcatheter Mitral Valve Replacement for Severe Mitral Annular Calcification: Primary Outcomes from the SUMMIT-MAC Study.
Journal: Journal of the American College of Cardiology
Published: September 09, 2025
Similar Doctors
Distinguished in Rheumatic Fever
Dr. Ujjaval M. Patel
Cardiology | Interventional Cardiology
Distinguished in Rheumatic Fever
Dr. Ujjaval M. Patel
Cardiology | Interventional Cardiology

Midwest Heart And Vascular Specialists LLC

5100 W 110th St, 
Overland Park, KS 
 (8.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ujjaval Patel is a Cardiologist and an Interventional Cardiologist in Overland Park, Kansas. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Rheumatic Fever. His top areas of expertise are Pediatric Myocarditis, Heart Attack, Aortic Regurgitation, Balloon Sinuplasty, and Angioplasty. Dr. Patel is currently accepting new patients.

Distinguished in Rheumatic Fever
Dr. Rajendran Sabapathy
Interventional Cardiology | Cardiology
Distinguished in Rheumatic Fever
Dr. Rajendran Sabapathy
Interventional Cardiology | Cardiology

Midwest Heart And Vascular Specialists LLC

5100 W 110th St, 
Overland Park, KS 
 (8.6 miles away)
Languages Spoken:
English, French, Hindi, Spanish
See accepted insurances
Accepting New Patients

Rajendran Sabapathy is an Interventional Cardiologist and a Cardiologist in Overland Park, Kansas. Dr. Sabapathy is rated as a Distinguished provider by MediFind in the treatment of Rheumatic Fever. His top areas of expertise are Pediatric Myocarditis, Aortic Regurgitation, Rheumatic Fever, Venous Insufficiency, and Pacemaker Implantation. Dr. Sabapathy is currently accepting new patients.

Distinguished in Rheumatic Fever
Dr. Craig Lundgren
Cardiology
Distinguished in Rheumatic Fever
Dr. Craig Lundgren
Cardiology

St. Joseph Medical Center

1000 Carondelet Dr, 
Kansas City, MO 
 (7.8 miles away)
913-956-2250
Languages Spoken:
English
See accepted insurances

Craig Lundgren is a Cardiologist in Kansas City, Missouri. Dr. Lundgren is rated as a Distinguished provider by MediFind in the treatment of Rheumatic Fever. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Arterial Embolism, and Carotid Artery Disease.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Allen's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 26 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile